The Dorset Formulary has been developed in associations with NHS Dorset Clinical Commissioning Group Dorset County Hospital NHS Foundation Trust Dorset Healthcare University NHS Foundation Trust Poole Hospital NHS Foundation Trust Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
The NetFormulary mobile application will no longer be available for use in Dorset as of May 2019.
This decision was based on the use of the application throughout Dorset, the increased access to technology for mobile healthcare teams and the functionality of the application and cost. This decision was approved by the Dorset Medicines Advisory Group of which clinicians from primary and secondary care are members.
It is recommended that if you wish to access the formulary from your mobile phone, then to use the internet browser and use the mobile website: http://www.dorsetformulary.nhs.uk/
Metoprolol shortage of supply
Please see here for details on the intermittent supply issues affecting metoprolol 50mg and 100mg. This document provides suggestions for alternative agents and management options.
Future availability of Adalat® (nifedipine) products
Please see here for details on the supply of Adalat® - There will be some out of stock periods for some preparations and long-term discontinuations.
The Dorset Opioid Prescribing for Chronic Pain: Resource Pack is now avalible
This is available on the front page of the formulary and can be found in chapter 04.07.02 (Opioid analgesics) in the links section at the bottom of the page.
Getting started: Use the search tool to find medicine of interest or browse by BNF chapter using the 'Chapters' Menu at top of page.
The Dorset Formulary aims to provide information on medicines supporting safe, evidence-based, cost-effective practice. Whilst the formulary contains links to relevant policies and guidelines, the prescriber retains the responsibility for the appropriate use of this information.
For further information on the development of the Dorset Formulary and participating organisations, please go to the About page.
Comments about any aspect of the formulary can be made by using the feedback tab at the top of this page.